Glycogen storage disease: genes and variants
Explore variant evidence for Glycogen storage disease across 8 analyzed proteins (GAA, G6PC1, PYGM, SLC37A4, AGL and 3 more). Linked ClinVar records include 363 pathogenic or likely pathogenic variants, 2,138 variants of uncertain significance and 234 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Glycogen storage disease
GAA: Lysosomal alpha-glucosidase
It degrades lysosomal glycogen to free glucose. Biallelic loss-of-function variants cause Pompe disease, ranging from severe infantile cardiomyopathy to later-onset progressive skeletal and respiratory muscle weakness.
214 ClinVar pathogenic / likely pathogenic and 801 uncertain variants in GAA have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
G6PC1: Glucose-6-phosphatase catalytic subunit 1
It catalyzes the final step of hepatic and renal glucose production by hydrolyzing glucose-6-phosphate to free glucose. Biallelic loss-of-function variants cause glycogen storage disease type Ia, with fasting hypoglycemia, lactic acidosis, hyperuricemia, hyperlipidemia, and hepatomegaly.
65 ClinVar pathogenic / likely pathogenic and 94 uncertain variants in G6PC1 have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
PYGM: Glycogen phosphorylase, muscle form
Muscle glycogen phosphorylase releases glucose-1-phosphate from glycogen during energy demand. Variants cause McArdle disease, which impairs exercise tolerance.
38 ClinVar pathogenic / likely pathogenic and 344 uncertain variants in PYGM have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
SLC37A4: Glucose-6-phosphate exchanger SLC37A4
It transports glucose-6-phosphate into the endoplasmic reticulum so glucose-6-phosphatase can release free glucose during fasting. Biallelic loss-of-function variants cause glycogen storage disease type Ib, with fasting hypoglycemia, hepatomegaly, neutropenia, and inflammatory bowel disease.
30 ClinVar pathogenic / likely pathogenic and 313 uncertain variants in SLC37A4 have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
AGL: Glycogen debranching enzyme
It is the glycogen debranching enzyme, combining transferase and glucosidase activities that remove branch points so glycogen can be fully broken down to glucose. Biallelic loss-of-function variants cause glycogen storage disease type III, with hepatomegaly, fasting hypoglycemia, and in many patients skeletal and cardiac myopathy.
14 ClinVar pathogenic / likely pathogenic and 820 uncertain variants in AGL have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
ALDOB: Fructose-bisphosphate aldolase B
It cleaves fructose-1-phosphate and fructose-1,6-bisphosphate during fructose and glucose metabolism in liver, kidney, and intestine. Biallelic loss-of-function variants cause hereditary fructose intolerance, in which fructose ingestion can trigger hypoglycemia, vomiting, and liver injury.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ALDOB have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
ASS1: Argininosuccinate synthase
It catalyzes formation of argininosuccinate from citrulline and aspartate in the urea cycle, enabling nitrogen disposal and arginine synthesis. Biallelic loss-of-function variants cause citrullinemia type I, which can lead to severe hyperammonemia.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ASS1 have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
GYS2: Glycogen [starch] synthase, liver
The liver form of glycogen synthase, which adds glucose units during glycogen production. Variants cause hepatic glycogen storage disease type 0.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GYS2 have source records linked to Glycogen storage disease. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Glycogen storage disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| G6PC1 G188R | 188 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| ALDOB N335K | 335 | Pathogenic / likely pathogenic (★★★★) | |
| GAA P285R | 285 | Pathogenic / likely pathogenic (★★★) | |
| GAA L291P | 291 | Pathogenic / likely pathogenic (★★★) | |
| GAA L299P | 299 | Pathogenic / likely pathogenic (★★★) | |
| GAA G334C | 334 | Pathogenic / likely pathogenic (★★★) | |
| GAA G335R | 335 | Pathogenic / likely pathogenic (★★★) | |
| GAA G335E | 335 | Pathogenic / likely pathogenic (★★★) | |
| GAA P361R | 361 | Pathogenic / likely pathogenic (★★★) | |
| GAA P361L | 361 | Pathogenic / likely pathogenic (★★★) | |
| GAA R375L | 375 | Pathogenic / likely pathogenic (★★★) | |
| GAA D404G | 404 | Pathogenic / likely pathogenic (★★★) | |
| GAA P482L | 482 | Pathogenic / likely pathogenic (★★★) | |
| GAA G483R | 483 | Pathogenic / likely pathogenic (★★★) | |
| GAA D489N | 489 | Pathogenic / likely pathogenic (★★★) | |
| GAA M519T | 519 | Pathogenic / likely pathogenic (★★★) | |
| GAA E521K | 521 | Pathogenic / likely pathogenic (★★★) | |
| GAA E521V | 521 | Pathogenic / likely pathogenic (★★★) | |
| GAA P522A | 522 | Pathogenic / likely pathogenic (★★★) | |
| GAA H572Q | 572 | Pathogenic / likely pathogenic (★★★) | |
| GAA R594P | 594 | Pathogenic / likely pathogenic (★★★) | |
| GAA R594H | 594 | Pathogenic / likely pathogenic (★★★) | |
| GAA R600H | 600 | Pathogenic / likely pathogenic (★★★) | |
| GAA S601W | 601 | Pathogenic / likely pathogenic (★★★) | |
| GAA G607D | 607 | Pathogenic / likely pathogenic (★★★) | |
| GAA S619R | 619 | Pathogenic / likely pathogenic (★★★) | |
| GAA G638V | 638 | Pathogenic / likely pathogenic (★★★) | |
| GAA D645Y | 645 | Pathogenic / likely pathogenic (★★★) | |
| GAA R660C | 660 | Pathogenic / likely pathogenic (★★★) | |
| GAA R672Q | 672 | Pathogenic / likely pathogenic (★★★) | |
| GAA R702L | 702 | Pathogenic / likely pathogenic (★★★) | |
| GAA Y766S | 766 | Pathogenic / likely pathogenic (★★★) | |
| GAA C103G | 103 | P-type | Pathogenic / likely pathogenic (★★★) |
| GAA L291F | 291 | Pathogenic / likely pathogenic (★★★) | |
| GAA G309R | 309 | Pathogenic / likely pathogenic (★★★) | |
| GAA D404N | 404 | Pathogenic / likely pathogenic (★★★) | |
| GAA P482R | 482 | Pathogenic / likely pathogenic (★★★) | |
| GAA A486P | 486 | Pathogenic / likely pathogenic (★★★) | |
| GAA P522S | 522 | Pathogenic / likely pathogenic (★★★) | |
| GAA S529V | 529 | Pathogenic / likely pathogenic (★★★) | |
| GAA L552P | 552 | Pathogenic / likely pathogenic (★★★) | |
| GAA I557S | 557 | Pathogenic / likely pathogenic (★★★) | |
| GAA I557F | 557 | Pathogenic / likely pathogenic (★★★) | |
| GAA R600C | 600 | Pathogenic / likely pathogenic (★★★) | |
| GAA S601L | 601 | Pathogenic / likely pathogenic (★★★) | |
| GAA G611D | 611 | Pathogenic / likely pathogenic (★★★) | |
| GAA T614K | 614 | Pathogenic / likely pathogenic (★★★) | |
| GAA G615R | 615 | Pathogenic / likely pathogenic (★★★) | |
| GAA G638W | 638 | Pathogenic / likely pathogenic (★★★) | |
| GAA G643R | 643 | Pathogenic / likely pathogenic (★★★) | |
| GAA D645N | 645 | Pathogenic / likely pathogenic (★★★) | |
| GAA D645E | 645 | Pathogenic / likely pathogenic (★★★) | |
| GAA G648S | 648 | Pathogenic / likely pathogenic (★★★) | |
| GAA R660H | 660 | Pathogenic / likely pathogenic (★★★) | |
| GAA R672L | 672 | Pathogenic / likely pathogenic (★★★) | |
| GAA R672W | 672 | Pathogenic / likely pathogenic (★★★) | |
| GAA R702C | 702 | Pathogenic / likely pathogenic (★★★) | |
| GAA R702H | 702 | Pathogenic / likely pathogenic (★★★) | |
| GAA R725W | 725 | Pathogenic / likely pathogenic (★★★) | |
| GAA W746C | 746 | Pathogenic / likely pathogenic (★★★) |
Showing 60 of 363.
Uncertain variants prioritized for review in Glycogen storage disease
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GAA G638E | 638 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G638W at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.987 | |
| GAA R600P | 600 | Conflicting reports (★) | +7: 7 other pathogenic changes within 3 positions; R600G at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.970 | |
| GAA C108Y | 108 | P-type | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; C108S at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.969 |
| G6PC1 G188D | 188 | Transmembrane | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G188S at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.906 |
| GAA G576D | 576 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; G576R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.937 | |
| GAA D616N | 616 | Conflicting reports (★) | +7: 10 other pathogenic changes within 3 positions; D616Y at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.886 | |
| GAA H372Y | 372 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; H372L at the same position is pathogenic; seen in 4.1e-06 of gnomAD DNA copies; REVEL 0.920 | |
| GAA C558Y | 558 | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; C558S at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.877 | |
| PYGM R490W | 490 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; R490P at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.892 | |
| GAA H568L | 568 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; H568R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.972 | |
| G6PC1 H119R | 119 | Transmembrane | Conflicting reports (★) | +7: 8 other pathogenic changes within 3 positions; H119D at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.948 |
| GAA G377S | 377 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G377R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.918 | |
| GAA G483V | 483 | Conflicting reports (★) | +7: 8 other pathogenic changes within 3 positions; G483W at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.817 | |
| GAA G528A | 528 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G528V at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.803 | |
| GAA Y292H | 292 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; Y292C at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.808 | |
| GAA T711A | 711 | Conflicting reports (★) | +7: T711S at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.938 | |
| GAA R672G | 672 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; R672L at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.829 | |
| AGL D627Y | 627 | Uncertain | +7: in a 3D region that tolerates change poorly (5R); D627G at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.952 | |
| GAA R702P | 702 | Uncertain (★★★) | +7: 3 other pathogenic changes within 3 positions; R702L at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.989 | |
| PYGM G157D | 157 | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; G157V at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.981 | |
| PYGM G136V | 136 | Uncertain (★★) | +7: 3 other pathogenic changes within 3 positions; G136D at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.986 | |
| PYGM G136S | 136 | Uncertain (★★) | +7: 3 other pathogenic changes within 3 positions; G136D at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.972 | |
| GAA W772C | 772 | Uncertain (★★★) | +7: W772R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.942 | |
| GAA Q743K | 743 | Uncertain (★) | +7: 5 other pathogenic changes within 3 positions; Q743R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.968 | |
| GAA C647F | 647 | Uncertain (★★★) | +7: 9 other pathogenic changes within 3 positions; C647W at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.908 | |
| GAA H572P | 572 | Uncertain (★★) | +7: 7 other pathogenic changes within 3 positions; H572Y at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.978 | |
| GAA D404V | 404 | Uncertain (★★) | +7: 5 other pathogenic changes within 3 positions; D404G at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.938 | |
| GAA H295Y | 295 | Uncertain (★) | +7: 3 other pathogenic changes within 3 positions; H295N at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.788 | |
| GAA H612P | 612 | Uncertain (★★) | +7: 10 other pathogenic changes within 3 positions; H612Q at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.831 | |
| SLC37A4 G115R | 115 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G115E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| GAA C647Y | 647 | Conflicting reports (★) | +6: 9 other pathogenic changes within 3 positions; C647W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 | |
| GAA S599F | 599 | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; S599Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 | |
| G6PC1 W63C | 63 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; W63R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89 |
| GAA L369Q | 369 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; L369P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.84 | |
| GAA P457H | 457 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; P457R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.86 | |
| GAA Y766H | 766 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; Y766S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.84 | |
| GAA Y455C | 455 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; Y455F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.82 | |
| PYGM R490Q | 490 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R490P at the same position is pathogenic; REVEL 0.960 | |
| GAA G643A | 643 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; G643R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.81 | |
| PYGM R161C | 161 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R161H at the same position is pathogenic; REVEL 0.957 |
Which prediction tools work for Glycogen storage disease
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 93 out of 100
- MetaLR: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (regulatory): 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 91 out of 100
- SIFT: 90 out of 100
- VARITY: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 89 out of 100
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 86 out of 100
- phyloP: 72 out of 100
- Pangolin: 54 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (splicing): 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Citrullinemia also has ClinVar records linked to ASS1 variants; they fall mostly in different places as the Glycogen storage disease variants (69 pathogenic / likely pathogenic).
Diseases related to Glycogen storage disease
- Cardiac arrhythmia, also linked to ASS1
- Citrullinemia, also linked to ASS1
- Type 2 diabetes mellitus, also linked to GAA
- Hereditary fructosuria, also linked to ALDOB
- Disorder of glycosylation, also linked to SLC37A4
- Phosphate transport defect, also linked to SLC37A4
- Glycogen storage disorder due to hepatic glycogen synthase deficiency, also linked to GYS2
Frequently asked questions
Which genes have records linked to Glycogen storage disease?
This view contains 8 analyzed proteins: GAA, G6PC1, PYGM, SLC37A4, AGL and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 363 pathogenic or likely pathogenic variants, 2,138 variants of uncertain significance and 234 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 76 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 3,002 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center